Organon's Q3: Mixed Results, Strong Profitability
Update: 2025-11-10
Description
Organons Q3 2025 results: Mixed but generally positive, with revenues slightly above predictions, non-GAAP profit per share beating estimates by 8.5%, and a modest stock increase. Despite a slight decrease in operating margin and lower full-year revenue guidance, the company remains focused on womens health.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel




